Dr. Burt W. Dubow, O.D., F.A.A.Q. has consulted with Nova Oculus for over 10 years. Prior to the Covid pandemic, he organized an advisory board of the most prominent retinal optometrists in the United States, most of whom are involved in the Optometric Retina Society.

These doctors would be considered the top KOLs in the United States. The advisory board was prepared to begin conducting clinical trials and studies to show the safety and efficacy of Nova Oculus treatments in preparation for applying for FDA approval.

Most of these original advisory board members are ready to re-convene and resume their investigations and research. They are palpably excited about the value of Nova Oculus in treating AMD and perhaps other retinal conditions.

Dr. Dubow has also recently recruited a valuable KOL optometrist and ophthalmology retinal specialist in Canada who are both eager to work with Nova Oculus when we are ready to begin FDA related clinical studies.